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Abstract
This report describes the preparation of a series of 17 novel racemic spirocyclic scaffolds that are
intended for the creation of compound libraries by parallel synthesis for biological screening. Each
scaffold features two points of orthogonal diversification. The scaffolds are related to each other in
four ways:
1. Through stepwise changes in the size of the nitrogen bearing ring.
2. Through the oxidation state of the carbon centered point of diversification.
3. Through the relative stereochemical orientation of the two diversification sites in those
members that are stereogenic.
4. Through the provision of both saturated and unsaturated versions of the furan ring in the
scaffold series derived from 3-piperidone.
The scaffolds provide incremental changes in the relative orientation of the diversity components
that would be introduced onto them. The scaffolds feature high sp3 carbon content which is
essential for the three dimensional exploration of chemical space. This characteristic is particularly
evident in those members of this family that bear two stereocenters, i.e. the two series derived
from 3-piperidone and 3-pyrrolidinone. In the series derived from 3-piperidone we were able to
“split the difference” between the two diastereomers by preparation of their corresponding
unsaturated version.
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The exploration of chemical space is often invoked by workers in high throughput synthesis
as a goal in library design. Chemical space can be envisioned as the microscopic volume
enveloping a molecule. As a molecule undergoes dynamic changes the envelope follows.
Flexible molecules have flexible space whereas rigid molecules have more static space.
The latter case enables controlled explorations of the relationship between spatial placement
and molecular properties. Static space can be surveyed by introducing incremental changes
into a well-defined molecule at its core, or scaffold, which orients its peripheral substituents.
The relative placement of peripheral substituents, both to the scaffold and each other,
determines the molecule’s properties. Diversity in compound libraries generally includes
variation of substituents around a scaffold, imparting certain characteristics such as degrees
of lipophilicity or hydrophilicity. Carefully choosing the peripheral elements reveals the
effect of their associated properties and placement on the properties of the molecule.
Spirocycles are ideal for this purpose. These molecules feature structural complexity with
incrementally variable placement of substituents.1,2 Accessible carbons can serve as a
“hinge” for “swinging” substituents in localized arcs as illustrated in Figure 1. A substituent
X can be oriented above, below or, in the unsaturated case, within the plane of the page.
This is analogous to a door which rests on hinges. The wall to which the hinges are attached
is rigid while the hinges serve as the point of flexibility. The three positions shown in Figure
1 define an arc of about 110° at the extremes and are distinct if the spiro carbon is
stereogenic. Synthesis of all three variations will reveal the effect on this molecule’s
properties of swinging X through the arc.
Our goal was to prepare a family of related novel spirocyclic scaffolds that would offer the
opportunity to effect incremental changes in the molecular architecture of derived compound
libraries. We were attracted to the idea that scaffolds having a high proportion of saturated
(sp3) carbons would enable the exploration of three dimensional space.3 We chose 1-Boc-3-
piperidone at the outset: first, because spirocyclization creates a stereocenter and, second, in
searching the online literature we found that simple spirocyclic derivatives of 3-piperidone
are relatively uncommon, especially when compared to those derived from 4-piperidone.
This report details our work towards deriving both saturated and unsaturated spirocyclic
scaffolds that correspond to those shown in Figure 1 from protected 2-N-substituted cyclic
ketones like 1-Boc-3-piperidone and its lower homologs.
Results and Discussion
Spirocyclic tetrahydrofuran (THF) scaffolds derived from N-Boc protected cyclic 2-
aminoketones
All spiro-THF scaffolds were constructed from N-Boc protected cyclic 2-aminoketones as
shown in Scheme 1. The cyclic ketones 1-3 were added to homoallyl magnesium bromide4
that was preexposed to CeCl3 to furnish tertiary alcohols 4-6.5 Epoxidation with mCPBA,
followed by spontaneous epoxide ring opening via a Baldwin favored 5-exo-tet nucleophilic
attack,6 afforded the racemic spirocyclic THF methanols 7-9.7 In no case was any evidence
observed for the formation of tetrahydropyran products via the alternative 6-endo-tet ring
closure mechanism. The diastereomers of 7 and 8 were separated. Further oxidation, under
different conditions, of 10a/10b, 11a/11b and 9 afforded the aldehydes 12a/12b, 13a/13b
and 14 or the acids 15a/15b, 16a/16b and 17.8 The behavior of the three sets of scaffolds
was sufficiently distinct that each case is described individually.
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Spirocyclic THFs derived from N-Boc-3-piperidone (1)
Addition of N-Boc-3-piperidone 1 to a pre-formed mixture of freshly prepared homoallyl
Grignard reagent and CeCl3 gave the tertiary alcohol 4 (Scheme 2). In the absence of CeCl3
the Grignard reagent addition to ketone 1 was lower yielding (≈25%) with the formation of
significant quantities of the reduction product N-Boc-3-piperidinol.9 We were delighted to
find that treatment of 4 with mCPBA at ambient temperature spontaneously afforded only
the alcohols 7 as a 1:1 mixture of diastereomers. These were readily separated, affording
10a and 10b. The epoxide intermediate was never detected during the reaction by 1H NMR
spectroscopy. The relative stereochemistries of 10a and 10b were established by correlation
NMR spectroscopy and X-ray crystallography as discussed below.
Alcohol 10a was oxidized to the corresponding aldehyde 12a or the acid 15a under different
conditions. Alcohol 10b, under the same conditions, gave evidence (1H NMR spectroscopy
of the crude product) of the formation of aldehyde 12b as expected. However, we were
unable to isolate 12b in satisfactory purity for full characterization purposes. It seemed that
12b was insufficiently stable to be purified by column chromatography. The acid 15b, by
contrast, was stable and fully characterized. We recommend that aldehyde 12b be generated
and promptly used without column chromatography.
In silico modeling of 10a and 10b using the MM2 force field indicate that H9 faces C2 in
the former and C4 in the latter. In the model structure for 10a the 1H-1H distance between
H9 and the pro-S H2 methylene is less than 3.3 Å, whereas the distance between H9 and
either the pro-R or pro-S H4 methylene is greater than 4.5 Å, leading to the prediction of a
strong or medium NOE between H9 and H2 and a weak or no NOE between H9 and H4 for
10a. On the other hand, in the model structure for 10b the 1H-1H distance between H9 and
either the pro-R or pro-S H2 methylene is greater than 4.5 Å, whereas the distance between
H9 and the pro-R H4 methylene is less than 3.3 Å, leading to the prediction of a strong or
medium NOE between H9 and H4 and a weak or no NOE between H9 and H2 (Figure 2).
On the basis of these observations, through-space interactions measured using the nuclear
Overhauser effect (NOE) were employed in lieu of a dihedral angle-based approach for
relative diastereospecific assignment of these spirocycles. Due to spectral overlap it is not
possible to unambiguously assign these diastereomers using 1D 1H selective and 2D 1H-1H
NOESY at 500 and 800 MHz. Going to higher dimensionality resolves crowded spectra. A
3D 1H-13C-1H HSQC-NOESY spectrum was acquired for 10a and 10b. A 2D strip of the
3D data at the 13C frequency corresponding to C2 for 10a was generated (see SI). There was
a resonance to H9, indicating that H2 and H9 are close in space for 10a. The analogous strip
for 10b shows no resonance that can be assigned to H9, indicating that H2 and H9 are not
close in space for 10b (see SI). 2D strips at the 13C frequency corresponding to C4 for 10a
and 10b, respectively, were also generated (see SI). For 10a, there is no resonance
corresponding to H9, indicating that H4 and H9 are not close in space. For 10b, there is a
peak corresponding to H9, indicating that H4 and H9 are close in space. Overall, the 3D
HSQC-NOESY indicates convincingly that diastereomers 10a and 10b possess the
structures shown in Figure 2.
As an additional check on the 3D HSQC-NOESY data, compound 10a was converted via
ester 18a to the HCl salt 19a (Scheme 3). Lyophilization of 19a followed by
recrystallization afforded crystals suitable for X-ray diffraction (see SI, Figure S3),
confirming the stereochemical assignment.
Spirocyclic THFs derived from N-Boc-3-pyrrolidinone (2)
N-Boc-3-pyrrolidinone 2 was exposed to homoallyl magnesium bromide in the presence of
CeCl3 as described above, giving the tertiary alcohol 5 (Scheme 4). mCPBA treatment of 5
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afforded the diastereomers 8 without the intermediate epoxide being detected by 1H NMR
spectroscopy. Our attempts to separate diastereomers 8 by various normal or reverse phase
chromatographic methods were unsuccessful. Instead, the mixture of diastereomers 8 was
converted to the corresponding p-OMe-benzoyl esters 20 which were separated by normal
phase chromatography, providing the individual diastereomers 21a and 21b. Ester
hydrolysis regenerated the alcohols as the single diastereomers 11a and 11b. Each
diastereomer was oxidized to either its corresponding aldehyde 13a and 13b or acid 16a and
16b as shown.
Aldehydes 13a and 13b, under normal handling conditions, gave evidence of instability. The
two aldehydes could be prepared and isolated but storage for a few days at rt produced
changes in the 1H NMR spectrum that suggested the formation of other unidentified
materials. We recommend that aldehydes 13a and 13b be used soon after preparation and
preferably without column chromatography. Alcohols 11a and 11b as well as acids 16a and
16b did not show evidence of similar behavior.10
The unambiguous assignment of the relative stereochemistry for the two isomers 11a and
11b by various 1D, 2D and 3D NMR experiments could not be made. Instead ester 21a was
N-deprotected and converted to the HCl salt 22a, which was lyophilized to afford crystals
suitable for X-ray crystallography (Scheme 5). Thus, 21a has the relative stereochemistry
shown in Scheme 5 (see SI). Its precursor 11a has the relative stereochemistry shown in
Scheme 4 and 11b has the opposite relative stereochemistry.
Spirocyclic THFs derived from N-Boc-3-azetidinone (3)
N-Boc-3-azetidinone 3 was exposed to homoallyl magnesium bromide/CeCl3 as described
above to afford the tertiary alcohol 6 (Scheme 6). In this case we anticipated that the ring
strain present in 3 might render the use of cerium less critical than for 1. The Grignard
reagent in the absence of CeCl3 afforded 6 in 53% yield. This yield was better than that
obtained using the Grignard alone with 1 but the improvement was insufficient to cause
discontinuation of the cerium modification. Epoxidation of 6 afforded the intermediate
epoxide (not shown) which, unlike in the cases of 4 and 5, could be observed, even after 24
h, as a mixture with 9 by 1H NMR spectroscopy (epoxide: δ 2.98-2.88 (m, 1H), 2.77 (dd, J =
4.7. 4.0 Hz, 1H), 2.52 (dd, J = 4.7, 2.8 Hz, 1H)).. Aging of the reaction for 48 h was required
to achieve full conversion to 9. Oxidation of 9 as described above gave the aldehyde 14 and
the carboxylic acid 17.11
Aldehyde 14 displayed evidence of instability. During an attempt to use variable
temperature NMR to coalesce rotamer populations, solutions of 14 in DMSO-d6 heated
above 50 °C rapidly darkened with loss of recognizable spectral signals. Further studies
showed that while 14 could be reproducibly generated and isolated, storage, even at 0 °C,
led to changes in the 1H NMR spectrum that suggested decomposition. Aldehyde 14 should,
when prepared, be used without delay. Alcohol 9 and acid 17 had no corresponding liability.
Spirocyclic dihydrofuran (DHF) scaffolds derived from N-Boc protected cyclic 2-
aminoketones
The synthetic plan for spiro-DHF containing scaffolds is shown in Scheme 7. The sequence
began with the N-Boc protected spirocyclic 3-furanones 23-25 which were prepared from N-
Boc protected cyclic 2-aminoketones 1-3 as previously reported by this laboratory.12 The 3-
furanones were converted to their corresponding tosylhydrazones (not shown) which were
obtained as mixtures of geometric isomers. These were treated with base to give the enol
ethers 26, 27 and 28, which were isolated in the indicated overall yields.13 Our plan was to
lithiate 26-28 at the enol ether α position using the method of Paquette, which was the most
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closely related precedent, and formylate them to afford the derived aldehydes.14,15
Reduction or oxidation16 would provide the alcohols or acids respectively.
Enol ether 26 was used as a model for optimizing the tert-BuLi lithiation required to
complete the synthesis. Deuterium incorporation was measured by quenching the carbanion
with CD3OD and examination of the relative integration of the enol ether signals in the 1H
NMR spectrum. In particular, the signal of the α proton at δ 6.24 (CDCl3) was diagnostic.
We developed conditions that gave both 100% deuterium incorporation and high mass
recovery (90%). Application of these conditions to formylation of 26 with DMF gave
aldehyde 29, although switching to N-formylpiperidine improved the yield of the reaction.
Reduction of 29 afforded alcohol 32 whereas oxidation afforded acid 33. Further
optimization of this sequence was not pursued.
Turning attention to enol ethers 27 and 28, neither afforded significant amounts of 30 or 31.
The reasons for the behavior of these last two substrates were not systematically
investigated. However, an indicator of unusual reactivity was observed during the lithiation
of 28. A small amount of a compound identified by 1H and 13C NMR spectroscopy as 34
(Figure 3) was isolated suggesting that lithiated 28 is exceptionally reactive. This reactivity
could cause unproductive processes to occur such as this unexpected Boc transfer.
Conclusions
We have successfully synthesized a series of 17 new spirocyclic scaffolds derived from
three N-Boc protected cyclic 2-aminoketones. These scaffolds can be prepared in sufficient
quantities for further elaboration. This constitutes a method of constructing building blocks
for exploring chemical space incrementally in three dimensions. In particular the fully
saturated THF containing scaffolds could be obtained in amounts that are suitable for
diversification using parallel synthesis. Syntheses of compound libraries derived from some




All air and moisture sensitive reactions were carried out in flame- or oven-dried glassware
under argon atmosphere using standard gas tight syringes, cannula, and septa. Stirring was
achieved with oven-dried, magnetic stir bars. mCPBA was purchased as a 70%–75% by
weight product. CH2Cl2 was purified by passage through a purification system employing
activated Al2O3. Flash column chromatography was performed with SiO2 from Sorbent
Technology (30930M-25, Silica Gel 60A, 40–63 μm) or by using an automated
chromatography instrument with an appropriately sized column. Thin layer chromatography
was performed on silica gel 60F254 plates (EM-5717, Merck). Non-UV active compounds
were visualized on TLC using KMnO4 stain. 1H and 13C NMR spectra were recorded on
instruments operating at 400 or 500 MHz and 100 or 125 MHz respectively. High-resolution
mass spectrometry (HRMS) spectra were obtained on an ESI-TOF mass spectrometer. The
analytical method utilized a Waters Aquity BEH C18 column (2.1 × 50mm, 1.7 μm) eluting
with a linear gradient of 95% water (modified to pH 9.8 through addition of NH4OH) to
100% CH3CN at 0.6 mL/min flow rate where purity was determined using UV peak area at
214 nm.
3-Butenylmagnesium bromide—3-Butenylmagnesium bromide was prepared by the
reported procedure.4 A 100 mL rb flask was fitted with a reflux condenser and dropping
funnel with pressure equalizing side arm atop the condenser. The flask was charged with Mg
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powder (0.293 g, 12.1 mmol) which was activated by adding 1–2 mol% of iodine. After 5
min, THF (15 mL) was added. A solution of 4-bromobutene (1.02 mL, 10 mmol) in THF (4
mL) was added using a dropping funnel. Addition was carried out at a rate sufficient to
maintain a gentle reflux. After complete addition the mixture was heated to reflux for 1 h.
The solution was cooled to rt and used for further reactions.
Procedure for the preparation of alcohols (4) and (5)
A suspension of anhydrous powdered CeCl3 (2.56 g, 10.34 mmol) in THF (30 mL) was
stirred at rt under argon for 18 h giving a thick, finely divided white suspension. The
mixture was cooled to 0 °C and a solution of 3-butenylmagnesium bromide (10.34 mmol) in
THF was added dropwise via canula. The resulting suspension was stirred at this
temperature for 2 h. A solution of the ketone (1) or (2) (5.17 mmol) in THF (10.0 mL) was
added dropwise by syringe and the mixture was stirred at 0 °C for 1 h, then slowly warmed
to rt. After 1 h at rt the mixture was quenched with 5% aq AcOH (10 mL). The organic layer
was separated and the aq layer was extracted with Et2O (3 × 10 mL). The combined organic
layers were washed with water (1 × 10 mL), satd aq NaHCO3 (1 × 10 mL) and brine (1 × 10
mL), then dried over anhyd Na2SO4. Filtration of the mixture followed by evaporation of the
solvent gave the crude product which was purified by flash column chromatography using
20%–40% EtOAc/hexanes as eluent to give the desired compound.
tert-Butyl 3-(but-3-en-1-yl)-3-hydroxypiperidine-1-carboxylate (4)—(0.90 g, 67%,
colorless oil); 1H NMR (CDCl3, 500 MHz) δ 5.85 (ddt, J = 16.8, 10.1, 6.5 Hz, 1H), 5.06
(dq, J = 17.1, 1.7 Hz, 1H), 4.97 (dq, J = 10.3, 1.4 Hz, 1H), 3.86-3.43 (m, 2H), 2.99 (br s,
2H), 2.22-2.17 (m, 2H), 1.83-1.67 (m, 3H), 1.59-1.53 (m, 3H), 1.46 (s, 9H); 13C NMR
(DMSO, 125 MHz, 85 °C) δ 154.8, 139.9, 114.2, 78.8, 68.9, 53.8, 44.1, 37.9, 36.3, 28.7,
27.2, 21.9; IR (neat): 3405, 2977, 1671, 1407 cm−1; HRMS (ESI-TOF) m/z calcd for (M +
H)+ C14H26NO3)+ 256.1913, found 256.1892.
tert-Butyl 3-(but-3-en-1-yl)-3-hydroxypyrrolidine-1-carboxylate (5)—(1.11 g,
90%, colorless oil, mixture of rotamers). 1H NMR (CDCl3, 500 MHz) δ 5.87 (ddt, J = 16.9,
10.2, 6.6 Hz, 1H), 5.08 (dq, J = 17.1, 1.7 Hz, 1H), 5.00 (dq, J = 10.2, 1.4 Hz, 1H), 3.57 -
3.45 (m, 2H), 3.43-3.34 (m, 1H), 3.24 (dd, J = 21.5, 11.6 Hz, 1H), 2.23 (p, J = 8.0 Hz, 2H),
1.91-1.87 (m, 1H), 1.75 (ddt, J = 16.8, 11.9, 7.4 Hz, 3H), 1.46 (s, 9H); 13C NMR (CDCl3,
125 MHz) δ 154.7, 154.6, 138.39, 138.37, 115.2, 115.1, 79.9, 79.3, 79.1, 58.1, 57.8, 44.7,
44.2, 38.1, 37.9, 37.5, 28.9, 28.8, 28.5; IR (neat) 3406, 2979, 1671, 1407 cm−1; HRMS
(ESI-TOF) m/z calcd for (M + H)+ C13H24NO3)+ 242.1756, found 242.1746.
tert-Butyl 3-(but-3-en-1-yl)-3-hydroxyazetidine-1-carboxylate (6)—A suspension
of anhydrous powdered CeCl3 (0.493 g, 2.0 mmol) in THF (5.0 mL) was stirred for 18 h.
The resulting white suspension was cooled to −78 °C and a THF solution of 3-
butenylmagnesium bromide (0.203 mL, 2.0 mmol) was added dropwise. The resulting
suspension was stirred for an additional 2 h at −78 °C. A solution of (3) (0.171 g, 1.0 mmol)
in THF (1.0 mL) was added dropwise at −78 °C and the mixture was stirred for 1 h at −78
°C. The reaction was allowed to warm slowly to rt with stirring over a period of 16 h. The
mixture was quenched with 5% aq AcOH (5 mL). The organic layer was separated and the
aq layers were extracted with Et2O (3 × 10 mL). The combined organic layers were washed
with H2O, satd aq NaHCO3, brine and then dried over anhyd Na2SO4. Filtration of the
mixture and evaporation of the solvent provided a pale yellow solid that was purified by
silica gel column chromatography (40% EtOAc/hexanes) to give alcohol (6) as a colorless
oil that crystallizes on standing (0.166 g, 0.730 mmol, 73%). mp = 71.5–74.0 °C; 1H NMR
(CDCl3, 400 MHz) δ 5.95 - 5.82 (m, 1H), 5.12 (dq, J = 17.1, 1.7 Hz, 1H), 5.05 (dq, J = 10.1,
1.4 Hz, 1H), 3.90 (br d, ½ AB, J = 9.9 Hz, 2H), 3.82 (br d, ½ AB, J = 9.8 Hz, 2H), 2.22 (br
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dq, Jq = 9.4 Hz, Jd = 3.0 Hz, 2H), 2.25 - 2.19 (m, 2H), 2.01 (br s, 1H), 1.93 - 1.85 (m, 2H),
1.47 (s, 9H); 13C NMR (DMSO-d6, 100 MHz, 85 °C) δ 156.4, 139.1, 114.8, 78.8, 69.5,
62.5, 38.4, 28.6, 27.8; IR (neat) 3405, 2977, 1671, 1407 cm−1; HRMS (ESI-TOF) m/z calcd
for (M + H)+ C12H22NO3)+ 228.1600, found 228.1593.
Using the above procedure but with omission of CeCl3 gave alcohol (6) in 53% yield.
General Procedure for the Preparation of Spiro Alcohols (8), (10a), (10b)
To a solution of alcohol (4) or (5) (4.31 mmol) in CH2Cl2 (20 mL) at rt was added mCPBA
(1.59 g, 70 wt%, 6.45 mmol) in one portion. The resulting solution was stirred for 22 h
during which time a white precipitate formed. Aliquots were withdrawn and evaporated in
vacuo for 1H NMR spectroscopy to confirm consumption of the olefin (diagnostic olefin
signals as reported above). Additional charges of mCPBA were added if required. The
mixture was diluted with CH2Cl2 (20 mL) and satd aq NaHCO3 (10 mL) was added. The
organic layer was removed and the aq layer was extracted with CH2Cl2 (3 × 20 mL). The
combined organic phase was washed with brine and then dried over anhyd Na2SO4.
Filtration of the mixture followed by evaporation of the solvent gave a viscous oil which
was purified by flash chromatography using 50%–80% EtOAc/hexanes as eluent.
tert-Butyl 2-(hydroxymethyl)-1-oxa-7-azaspiro[4.4]nonane-7-carboxylate (8)—
Using the above procedure with (5) as starting material, silica gel chromatography with 80%
EtOAc/hexanes as eluent gave 0.95 g (83%) of an inseparable mixture of the two
diastereomers (8).
tert-Butyl 2-(hydroxymethyl)-1-oxa-7-azaspiro[4.5]decane-7-carboxylate (10a)
—Using the above procedure, with (4) as starting material, the crude product was
chromatographed on silica gel (60% EtOAc/hexanes) to give (10a) (0.39 g, 35%, the more
retained isomer, pale yellow oil, mixture of rotamers); 1H NMR (CDCl3, 500 MHz) δ 4.15
(br s, 1H), 3.70-3.66 (m, 1H), 3.53 - 3.35 (m, 3H), 3.23 - 3.08 (m, 2H), 2.01 (br s, 1H), 1.88
- 1.62 (m, 7H), 1.46 (s, 9H); 13C NMR (CDCl3, 125 MHz) δ 154.8, 81.2, 79.4, 78.5, 65.1,
52.0, 51.1, 44.3, 43.3, 36.7, 33.7, 28.4, 26.8, 23.2; IR (neat): 3444, 2933, 1688, 1670 cm−1;
HRMS (ESI-TOF) m/z calcd for (M + H)+ C14H26NO4)+ 272.1862, found 272.1851.
tert-Butyl 2-(hydroxymethyl)-1-oxa-7-azaspiro[4.5]decane-7-carboxylate (10b)
—Using the above procedure, with (4) as starting material, the crude product was
chromatographed on silica gel (60% EtOAc/hexanes) to give (10b) (0.43g, 37%, the less
retained isomer, pale yellow oil); 1H NMR (CD3OD, 400 MHz) δ 4.08 (td, J = 7.3, 4.1 Hz,
1H), 3.73 - 3.40 (m, 4H), 3.29 - 3.01 (m, 2H), 2.13 - 1.60 (m, 7H) 1.48 (s, 10H); 13C NMR
(DMSO-d6, 125 MHz, 85 °C) δ 154.8, 80.8, 80.1, 79.0, 64.8, 53.4, 43.9, 36.4, 34.2, 28.7,
27.8, 23.1; IR (neat): 3407, 2934, 1691, 1670, 1424 cm−1; HRMS (ESI-TOF) m/z calcd for
(M + H)+ C14H26NO4)+ 272.1862, found 272.1850.
tert-Butyl 6-(hydroxymethyl)-5-oxa-2-azaspiro[3.4]octane-2-carboxylate (9)—
mCPBA (1.35 g, 70 wt%, 5.48 mmol) was added in one portion to a solution of (6) (0.5 g,
2.20 mmol) in CH2Cl2 (25 mL). The resulting solution was stirred for 48 h during which
time a white precipitate formed. The mixture was diluted with CH2Cl2 (10 mL) and satd aq
NaHCO3 (10 mL) was added. The organic layer was removed and the aq layer was extracted
with CH2Cl2 (3 × 10 mL). The combined organic layers were washed with brine and then
dried over anhyd Na2SO4. Filtration of the mixture followed by evaporation of the solvent in
vacuo gave a viscous oil that was purified by flash chromatography (10–45% EtOAc/
hexanes) to give (9) (0.23 g, 0.945 mmol, 43%) as a colorless oil. 1H NMR (CDCl3, 400
MHz) δ 4.15 (ddd, J = 4.8, 3.5, 1.7 Hz, 1H), 4.02 (dd, J = 17.6, 1.0 Hz, 2H), 3.91 - 3.86 (m,
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2H), 3.71 (dd, J = 11.7, 3.3 Hz, 1H), 3.50 (dd, J = 11.7, 5.8 Hz, 1H), 2.19 - 2.08 (m, 2H),
2.01 - 1.94 (m, 1H), 1.76 (dd, J = 12.5, 8.0 Hz, 1H), 1.46 (s, 9H); 13C NMR (DMSO-d6, 100
MHz, 85 °C) δ 156.2, 80.7, 78.9, 78.6, 64.3, 62.8, 62.2, 35.6, 28.6, 27.2; IR (neat) 3427,
2974, 1678, 1392 cm−1; HRMS (ESI-TOF) m/z calcd for (2M + H)+ (C24H43N2O8)+
487.3019, found 487.3028 (base peak); m/z calcd for (M + H)+ (C12H22NO4)+ 245.1549,
found 245.1575.
tert-Butyl 2-(((4-methoxybenzoyl)oxy)methyl)-1-oxa-7-azaspiro[4.5]decane-7-
carboxylate (18a)—para-Methoxybenzoyl chloride (0.23 g, 1.38 mmol) was added to a
solution of alcohol (10a) (0.187 g, 0.689 mmol) in dry py (2 mL) at rt under Ar. After 19 h,
py was evaporated in vacuo. The residue was diluted with DCM (5 mL) and water (5 mL).
The organic layer was recovered and the aq layer was extracted with DCM (2 × 5 mL). The
combined organic extracts were washed with 0.5 N aq HCl (2 × 10 mL), water (1 × 10 mL)
and brine (1 × 10 mL), then dried over anhyd Na2SO4. After filtration of the mixture, all
volatiles were evaporated in vacuo and the crude product was purified by silica gel column
chromatography using 20–40% EtOAc/hexanes as eluent to give 0.24 g (86%) of pure
compound (18a) (0.24 g, 86%, colorless oil, mixture of two rotamers); 1H NMR (400 MHz,
CDCl3) δ 7.95 – 7.91 (m, 2H), 6.86 – 6.83 (m, 2H), 4.32 – 4.17 (m, 3H), 3.79 (s, 3H), 3.60 –
3.35 (m, 2H), 3.03 (t, J = 14.2 Hz, 2H), 2.08 (br s, 1H), 1.90 – 1.77 (m, 2H), 1.73 – 1.54 (m,
5H), 1.38 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 166.2, 163.4, 155.1, 131.7, 122.5, 113.6,
81.5, 79.4, 76.1, 66.8, 55.4, 36.8, 33.1, 28.5, 27.8, 23.4; IR (neat) 2976, 1712, 1688, 1605,
1251, 1163 cm−1; HRMS (ESI-TOF) m/z calcd for (M + H)+ (C22H32NO6)+ 406.2229,
found 406.2247.
2-(((4-methoxybenzoyl)oxy)methyl)-1-oxa-7-azaspiro[4.5]decan-7-ium chloride
(19a)—TFA (0.31 mL, 4.05 mmol) was added to a solution of (18a) (69 mg, 0.17 mmol) in
DCM (2 mL) at rt. The reaction mixture slowly became light yellow and was stirred at rt for
1 h. All volatiles were removed in vacuo. Saturated aq NaHCO3 (4 mL) was added and the
solution was stirred at rt for 2 h. The reaction mixture was extracted with DCM (3 × 3 mL).
The organic extracts were evaporated to give the free amine which was suspended in
deionized water (1 mL) and acidified with 0.1 N aq HCl to pH ~2 (by pH meter). The
mixture was stirred further for 30 min until homogenous and then lyophilized over a period
of 48 h to give a clear viscous oil. The oil was layered with isopropyl acetate and heated to
just below reflux, then MeOH was slowly added dropwise until homogenous. The solution
was allowed to stand in a loosely capped vial in the hood for 3 d, affording X-ray quality
crystals of (19a). HRMS (ESI-TOF) m/z calcd for (M + H)+ (C17H24NO4)+ 306.1705, found
306.1720.
tert-Butyl 2-(((4-methoxybenzoyl)oxy)methyl)-1-oxa-7-azaspiro[4.4]nonane-7-
carboxylate (21a) and (21b)—para-Methoxybenzoyl chloride (4.51 g, 26.4 mmol) was
added to a solution of alcohols (8) (3.40 g, 13.21 mmol) in dry py (13 mL) at rt under Ar.
After 20 h, py was evaporated in vacuo. The residue was diluted with DCM (50 mL) and
water (50 mL). The organic layer was recovered and the aq layer was extracted with DCM
(2 × 20 mL). The combined organic extracts were washed with 0.5 N aq HCl (2 × 50 mL),
water (1 × 50 mL) and brine (1 × 50 mL), then dried over anhyd Na2SO4. After filtration of
the mixture, all volatiles were evaporated in vacuo and the crude product (20) was purified
by silica gel column chromatography using 30% EtOAc/hexanes as eluent to give a total of
3.72 g (72%) of pure diastereomers (21a) and (21b) (1:1 ratio).
(21a): (1.86 g, 36%, the less retained isomer, colorless oil, mixture of two rotamers); 1H
NMR (CDCl3, 500 MHz) δ 7.95 - 7.92 (m, 2H), 6.87 - 6.84 (m, 2H), 4.30 - 4.21 (m, 3H),
3.79 (s, 3H), 3.43 - 3.33 (m, 3H), 3.18 (t, J = 11.2 Hz, 1H), 2.04 (dt, J = 13.4, 6.6 Hz, 1H),
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2.00 - 1.88 (m, 3H), 1.88 - 1.72 (m, 2H), 1.38 (s, 9H); 13C NMR (CDCl3, 125 MHz) δ
166.2, 163.43, 163.41, 154.6, 154.5, 131.7, 122.44, 122.40, 113.6, 88.8, 88.0, 79.22, 79.18,
76.6, 66.4, 56.2, 55.7, 55.4, 45.1, 44.7, 37.4, 36.8, 33.8, 33.5, 28.5, 28.32, 28.30; IR (neat)
2972, 1712, 1693, 1606, 1403 cm−1; HRMS (ESI-TOF) m/z calcd for (2M + H)+
(C42H59N2O12)+ 783.4068, found 783.4072 (base peak); m/z calcd for (M + H)+
(C21H30NO6)+ 92.2073, found 392.2071.
(21b): (1.86 g, 36%, the more retained isomer, colorless oil, mixture of two rotamers); 1H
NMR (CDCl3, 500 MHz) δ 7.95 - 7.93 (m, 2H), 6.87 - 6.84 (m, 2H), 4.31 - 4.21 (m, 3H),
3.79 (s, 3H), 3.42 - 3.22 (m, 4H), 2.08 - 1.95 (m, 3H), 1.87 - 1.80 (m, 2H), 1.73 (tt, J = 12.3,
8.3 Hz, 1H), 1.38 (s, 4.0 H), 1.37 (s, 5.0 H); 13C NMR (CDCl3, 125 MHz) δ 166.26, 166.24,
163.4, 154.49, 154.47, 131.72, 131.71, 122.40, 122.38, 113.65, 113.64, 88.8, 88.0, 79.24,
79.18, 76.7, 66.40, 66.38, 56.6, 56.2, 55.4, 45.0, 44.6, 36.8, 36.2, 34.1, 33.9, 28.5, 28.3,
28.2; IR (neat) 2971, 1714, 1694, 1606, 1404 cm−1; HRMS (ESI-TOF) m/z calcd for (M +
H)+ (C21H30NO6)+ 392.2073, found 392.2074.
tert-Butyl 2-(hydroxymethyl)-1-oxa-7-azaspiro[4.4]nonane-7-carboxylates (11a)
and (11b)—A solution of NaOMe in MeOH (0.83 mL, 25 wt%, 3.83 mmol) was added to a
solution of p-methoxybenzoate (21a) or (21b) (0.75 g, 1.92 mmol) in anhyd MeOH (10 mL)
at rt. The reaction mixture was stirred at rt for 16h. The solvent was evaporated in vacuo and
the residue was treated with 5% aq. acetic acid (10 mL). The reaction mixture was extracted
with DCM (3 × 10 mL). The combined organic extracts were washed with satd aq NaHCO3
solution (2 × 10 mL), and brine (1 × 20 mL), then dried over anhyd Na2SO4. After filtration
of the mixture, all volatiles were removed and the crude product was purified by column
chromatography using 80% EtOAc/hexanes as eluent.
(11a): (0.47 g, 95%, colorless oil, mixture of two rotamers); 1H NMR (CDCl3, 500 MHz) δ
4.06 – 4.02 (m, 1H), 3.64 (dd, J = 11.5, 3.3 Hz, 1H), 3.46 - 3.33 (m, 4H), 3.16 (t, J = 10.9
Hz, 1H), 1.94 - 1.76 (m, 6H), 1.39 (s, 9H); 13C NMR (CDCl3, 125 MHz) δ 154.6, 154.5,
88.7, 87.9, 79.30, 79.27, 79.23, 79.0, 65.1, 64.9, 56.2, 55.6, 45.1, 44.7, 37.3, 36.9, 33.9,
33.7, 28.5, 27.31, 27.26; IR (neat) 3432, 2973, 1692, 1673, 1401 cm−1; HRMS (ESI-TOF)
m/z calcd for (M + H−Boc)+ (C8H16NO2)+ 158.1181, found 158.1176.
(11b): (0.46 g, 93%, colorless oil, mixture of two rotamers); 1H NMR (CDCl3, 500 MHz) δ
4.05 (dddd, J = 7.5, 6.5, 5.5, 3.3 Hz, 1H), 3.65 - 3.61 (m, 1H), 3.46 - 3.21 (m, 5H), 1.98 -
1.89 (m, 4H), 1.78 - 1.69 (m, 2H), 1.39 (s, 9H); 13C NMR (CDCl3, 125 MHz) δ 154.6,
154.5, 88.7, 87.9, 79.38, 79.31, 79.26, 79.16, 77.2, 65.1, 65.0, 56.6, 56.2, 45.1, 44.6, 36.7,
36.1, 34.1, 33.9, 28.5, 27.31, 27.26; IR (neat) 2972, 1692, 1673, 1402 cm−1; HRMS (ESI-
TOF) m/z calcd for (M + H−Boc)+ (C8H16NO2)+ 158.1181, found 158.1171.
tert-Butyl 2-formyl-1-oxa-7-azaspiro[4.5]decane-7-carboxylate (12a)—A solution
of oxalyl chloride (0.017 mL, 0.19 mmol) in CH2Cl2 (2.0 mL) was cooled to −78 °C and a
solution of DMSO (0.027 mL, 0.38 mmol) in CH2Cl2 (0.5 mL) was added dropwise. The
resulting solution was stirred for 15 min at this temperature. A solution of the alcohol (10a)
or (10b) (0.128 mmol) in CH2Cl2 (1.0 mL) was added dropwise and the mixture was stirred
for 1 h at −78 °C. Triethylamine (0.089 mL, 0.64 mmol) was then added dropwise and the
mixture was allowed to warm slowly to rt over a period of 1 h. After 1h, the reaction was
diluted with CH2Cl2 (2 mL) and water (5 mL). The organic phase was removed and the aq
layer was extracted with CH2Cl2 (3 × 2 mL). The combined organic layers were washed
with H2O (1 × 5 mL), brine (1 × 5 mL), and dried over anhyd Na2SO4. After filtration of the
mixture the solvent was evaporated in vacuo and the crude product was purified by column
chromatography using 60%–80% EtOAc/hexanes as eluent. ((12a): 0.028 g, 81%; colorless
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oil, mixture of two rotamers); 1H NMR (CDCl3, 400 MHz) δ 9.60 (d, J = 1.5 Hz, 1H), 4.30
(br s, 1H), 3.46 - 3.36 (m, 2H), 3.16 - 3.07 (m, 2H), 2.25 - 2.11 (m, 1H), 2.03 (ddt, J = 13.5,
8.5, 5.0 Hz, 1H), 1.87 - 1.80 (m, 1H), 1.73 (dddd, J = 12.5, 8.5, 6.8, 4.1 Hz, 2H), 1.66 - 1.57
(m, 2H), 1.49 - 1.43 (m, 1H), 1.38 (s, 9H); 13C NMR (CDCl3, 100 MHz) δ 202.7, 154.9,
82.8, 82.6, 79.6, 51.9, 51.0, 44.2, 43.2, 36.3, 33.0, 28.4, 27.1, 23.2; IR (neat) 2974, 1733,
1686, 1420 cm−1; HRMS (ESI-TOF) m/z calcd for (M + H)+ (C14H24NO4)+ 270.1705,
found 270.1705.
tert-Butyl 2-formyl-1-oxa-7-azaspiro[4.4]nonane-7-carboxylate (13a) and (13b)
—Following the above procedure for preparation of (12a) and using either (11a) or (11b) as
starting material, aldehydes (13a) or (13b) were obtained.
(13a): 0.027 g, 82%, colorless oil, mixture of two rotamers); 1H NMR (CDCl3, 400 MHz) δ
9.68 (d, J = 1.6 Hz, 1H), 4.37 (q, J = 7.3 Hz, 1H), 3.55 - 3.44 (m, 3H), 3.28 (dd, J = 11.5, 4.2
Hz, 1H), 2.29 - 2.20 (m, 1H), 2.15 - 1.99 (m, 3H), 1.95 - 1.86 (m, 2H), 1.46 (s, 9H); 13C
NMR (CDCl3, 100 MHz) δ 202.3, 202.1, 154.5, 154.4, 90.2, 89.4, 82.8, 82.7, 79.4, 56.0,
55.5, 45.1, 44.6, 36.9, 36.3, 33.3, 32.9, 28.5, 27.62, 27.58; IR (neat) 2974, 1733, 1691, 1403
cm−1; HRMS (ESI-TOF) m/z calcd for (2M + H)+ (C26H43N2O8)+ 511.3019, found
511.3011 (base peak); m/z calcd for (M + H)+ (C13H22NO4)+ 256.1549, found 256.1562.
(13b): (0.030 g, 87% colorless oil, mixture of two rotamers); 1H NMR (CDCl3, 500 MHz) δ
9.69 - 9.67 (m, 1H), 4.41 - 4.33 (m, 1H), 3.51 (ddt, J = 22.7, 8.8, 5.2 Hz, 3H), 3.35 (dd, J =
19.8, 11.6 Hz, 1H), 2.29 - 2.23 (m, 1H), 2.15 - 2.03 (m, 2H), 1.96 (dt, J = 14.5, 7.2 Hz, 2H),
1.91 - 1.81 (m, 1H), 1.47 (s, 9H); 13C NMR (CDCl3,125 MHz) δ 202.5, 202.2, 154.4, 90.3,
89.5, 82.9, 82.8, 79.5, 79.4, 56.1, 55.8, 45.1, 44.6, 36.7, 36.1, 33.3, 28.5, 27.9, 27.6; IR
(neat) 2974, 1733, 1692, 1403 cm−1; HRMS (ESI-TOF) m/z calcd for (M + H)+
(C13H22NO4)+ 256.1549, found 256.1561.
tert-Butyl 6-formyl-5-oxa-2-azaspiro[3.4]octane-2-carboxylate (14)—A solution
of oxalyl chloride (0.185 mL, 2.14 mmol) in CH2Cl2 (5.0 mL) was cooled to −78 °C and a
solution of DMSO (0.304 mL, 4.27 mmol) in CH2Cl2 (2.0 mL) was added drop wise. The
resulting solution was stirred for 15 min at this temperature. A solution of (9) (0.104 g,
0.427 mmol) in CH2Cl2 (2.5 mL) was then added drop wise and the mixture was stirred for
1 h at −78 °C. Triethylamine (0.894 mL, 6.41 mmol) was added and the mixture was
allowed to warm slowly to rt. After 30 min the reaction was diluted with CH2Cl2 (10 mL)
and satd aq NaHCO3 (10 mL). The organic phase was separated and the aq layer was
extracted with CH2Cl2 (3 × 10 mL). The combined organic layers were washed with H2O
(10 mL), brine (10 mL), and then dried over anhyd Na2SO4. Filtration of the mixture and
evaporation of the solvent, followed by flash chromatography (10–50% EtOAc/Hex), gave
the aldehyde (14) (0.06 g, 0.25 mmol, 58%) as a colorless oil. 1H NMR (CDCl3, 400 MHz)
δ 9.67 (d, J = 1.6 Hz, 1H), 4.41 (ddd, J = 7.9, 6.1, 1.6 Hz, 1H), 4.13 (ddd, J = 11.8, 9.2, 1.1
Hz, 2H), 3.91 (ddd, J = 9.2, 5.6, 1.1 Hz, 2H), 2.28 - 1.99 (m, 4H), 1.46 (s, 9H); 13C NMR
(100 MHz, CDCl3) δ 201.3, 156.4, 83.3, 79.84, 79.81, 77.2, 61.3 (broad peak), 35.2, 28.4,
26.8; IR (neat) 2972, 2876, 1730, 1698, 1399 cm−1; HRMS (ESI-TOF) m/z calcd for
negative ion (M − H)− (C12H18NO4)− 240.1236, found 240.1214.
7-(tert-Butoxycarbonyl)-1-oxa-7-azaspiro[4.5]decane-2-carboxylic acid (15a)
and (15b)—NMO•H2O (0.446 g, 3.3 mmol) was added at rt to the solution of alcohol (10a)
or (10b) (0.33 mmol) in CH3CN (5 mL). TPAP (11.6 mg, 0.033 mmol) was added and the
reaction mixture was further stirred at rt for 16 h in a closed vessel. Water (2 mL) was added
and the reaction mixture was acidified with satd aq sodium hydrogen sulfate to pH ~3. DCM
(10mL) was added and the organic phase was separated. The aq phase was extracted with
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DCM (3 × 3 mL). The combined organic extracts were washed with water (1 × 10 mL),
brine (1 × 10 mL) and dried over anhyd Na2SO4. The mixture was filtered and the solvent
was evaporated in vacuo. The crude product was purified using 5%–20% MeOH/DCM as
eluent.
(15a): (0.050 g, 53%, white solid); mp 94.0–96.0 °C; 1H NMR (CDCl3, 500 MHz) δ 9.24 (s,
1H), 4.58 (dd, J = 8.3, 4.2 Hz, 1H), 3.71 – 3.41 (m, 2H), 3.24 - 3.07 (m, 2H), 2.43 (br s, 1H),
2.23 (br s, 1H), 1.94 (ddd, J = 12.3, 8.1, 4.3 Hz, 1H), 1.89 – 1.74 (m, 3H), 1.66 (dt, J = 12.2,
8.7 Hz, 1H), 1.54 - 1.46 (m, 10H); 13C NMR (CDCl3, 125 MHz) δ 176.1, 155.1, 154.7,
83.7, 79.8, 76.4, 51.8, 50.8, 44.2, 43.2, 36.3, 32.7, 32.5, 29.5, 28.4, 23.4, 23.22; IR (neat)
2935, 1749, 1688, 1647, 1423 cm−1; HRMS (ESI-TOF) m/z calcd for (M + H−Boc)+
(C9H16NO3)+ 186.1130, found 186.1126.
(15b): (0.059 g, 63%, colorless oil); 1H NMR (CDCl3, 400 MHz) δ 4.51 (t, J = 7.2 Hz, 1H),
4.07 (d, J = 13.0 Hz, 2H), 2.94 - 2.71 (m, 2H), 2.41 (dq, J = 13.5, 7.0 Hz, 1H), 2.25 (dq, J =
12.8, 7.6 Hz, 1H), 1.94 - 1.79 (m, 3H), 1.74 (dt, J = 12.8, 7.8 Hz, 1H), 1.63 - 1.54 (m, 2H),
1.50 (s, 9H); 13C NMR (CDCl3, 100 MHz) δ 174.5, 157.8, 83.8, 80.9, 77.9, 53.4, 45.7, 35.9,
34.5, 30.5, 28.4, 22.5; IR (neat) 2936, 1751, 1689, 1659, 1423 cm−1; HRMS (ESI-TOF) m/z
calcd for (M + H−Boc)+ (C9H16NO3)+ 186.1130, found 186.1136.
7-(tert-Butoxycarbonyl)-1-oxa-7-azaspiro[4.4]nonane-2-carboxylic acid (16a)
and (16b)—Using the above procedure for the preparation of acids (15a/15b) with (11a) or
(11b) as starting materials the acids (16a) and (16b) were obtained.
(16a): (0.049 g, 55%, colorless oil, mixture of two rotamers); 1H NMR (CDCl3, 500 MHz)
δ 8.51 (br s, 1H), 4.57 (dd, J = 8.6, 5.6 Hz, 1H), 3.55 - 3.43 (m, 3H), 3.28 (t, J = 11.2 Hz,
1H), 2.40 (dq, J = 13.0, 7.8 Hz, 1H), 2.31 - 2.13 (m, 2H), 2.10 - 1.81 (m, 3H), 1.45 (s,
9H); 13C NMR (CDCl3, 125 MHz) δ 176.5, 176.3, 154.7, 154.6, 90.6, 89.9, 79.69, 79.64,
77.2 76.6, 76.4, 56.1, 55.5, 45.1, 44.6, 36.6, 36.1, 33.2, 32.9, 30.3, 30.2, 28.5; IR (neat)
2975, 1738, 1690, 1666, 1640, 1412 cm−1; HRMS (ESI-TOF) m/z calcd for (2M + H)+
(C26H43N2O10)+ 543.2918, found 543.2925 (base peak); m/z calcd for (M + H)+
(C13H22NO5)+ 272.1498, found 272.1509.
(16b): (0.047 g, 53%, colorless oil, mixture of two rotamers); 1H NMR (CDCl3, 500 MHz)
δ 7.26 (br s, 1H), 4.57 (dt, J = 9.0, 4.4 Hz, 1H), 3.67 - 3.35 (m, 4H), 2.46 - 2.36 (m, 1H),
2.26 - 2.18 (m, 1H), 2.10 - 2.01 (m, 2H), 1.97 - 1.90 (m, 1H), 1.82 (tt, J = 12.8, 8.5 Hz, 1H),
1.46 (s, 9H); 13C NMR (CDCl3, 125 MHz) δ 175.8, 175.3, 154.8, 154.6, 90.8, 89.9, 79.8,
79.7, 76.5, 55.9, 55.5, 45.0, 44.5, 36.8, 36.2, 33.1, 30.2, 28.5; IR (neat) 2974, 1739, 1691,
1667, 1645, 1411 cm−1; HRMS (ESI-TOF) m/z calcd for (M + H)+ (C13H22NO5)+
272.1498, found 272.1509.
2-(tert-Butoxycarbonyl)-5-oxa-2-azaspiro[3.4]octane-6-carboxylic acid (17)—A
25 mL rb flask was charged with NMO•0.21H2O (0.481 g, 4.11 mmol), water (0.037 mL,
2.0 mmol) and alcohol (9) (0.100 g, 0.41 mmol) as a solution in CH2Cl2 (2.0 mL).
Tetrapropylammonium perruthenate (14.5 mg, 0.041 mmol, 10 mol%) was added to this
mixture at rt. The mixture was stirred for 30 min during which time the color changed from
green to yellow. The reaction was quenched with 5% aq acetic acid (5 mL). The organic
layer was separated and the aq layer was extracted with CH2Cl2 (3 × 10 mL). The combined
organic layers were washed with brine and dried over anhyd Na2SO4. After filtration of the
mixture, evaporation of the solvent gave a viscous oil that was purified by flash
chromatography to provide (17) (0.055 g, 0.214 mmol, 52%) as white crystalline solid. mp =
123.5–127.3 °C; 1H NMR (CDCl3, 400 MHz) δ 4.50 (dd, J = 8.1, 5.3 Hz, 1H), 4.14 (d, J =
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9.4 Hz, 1H), 4.03 (d, J = 9.3 Hz, 1H), 3.83 (ddd, J = 9.3, 4.5, 1.1 Hz, 2H), 2.36 - 2.23 (m,
1H), 2.20 - 2.00 (m, 3H), 1.37 (s, 9H); 13C NMR (DMSO-d6, 125 MHz, 85 °C) δ 173.80,
156.4, 80.1, 79.3, 77.5, 62.5, 61.8, 35.0, 29.5, 28.6. IR (neat) 2373, 2924, 1740, 1702, 1428
cm−1; HRMS (ESI-TOF) m/z calcd for (M + H)+ (C12H20NO5)+ 258.1341, found 258.1346.
1-Oxa-7-azaspiro[4.4]nonan-2-ylmethyl 4-methoxybenzoate hydrochloride
(22a)—TFA (0.31 mL, 4.05 mmol) was added to a solution of (21a) (66 mg, 0.17 mmol) in
DCM (2 mL) at rt. The reaction mixture slowly became light yellow and was stirred at rt for
1 h. All volatiles were removed in vacuo. Saturated aq NaHCO3 (4 mL) was added and the
solution was stirred at rt for 2 h. The reaction mixture was extracted with DCM (3 × 3 mL).
The organic extracts were evaporated to give the free amine which was suspended in
deionized water (1 mL) and acidified with 0.1 N aq HCl to pH ~2 (by pH meter). The
mixture was stirred further for 30 min until homogenous and then lyophilized over a period
of 48 h to give crystals of 22a. HRMS (ESI-TOF) m/z calcd for (M − HCl + H)+
(C16H22NO4)+ 292.1549, found 292.1532.
tert-Butyl 1-oxa-7-azaspiro[4.5]dec-2-ene-7-carboxylate (26)—A solution of (23)
(0.559 g, 2.189 mmol) and 4-methylbenzenesulfonohydrazide (0.510 g, 2.740 mmol) in
EtOH (5.47 mL) was heated to reflux for 4.5 h. The reaction mixture was cooled, diluted
with water and DCM, and the layers separated. The aq layer was extracted with DCM (x3)
and the combined organic layers were dried over anhyd MgSO4, filtered and concentrated
under vacuum. The crude material was chromatographed on silica gel (20 to 40% EtOAc in
hexanes) to afford the tosylhydrazones (0.925 g, 85%) as a white, amorphous solid that
appeared by 1H NMR spectroscopy to be a mixture of the corresponding geometric isomers.
This compound was taken to the next step without further characterization.
In a procedure similar to that of Smith,13 to a solution of the tosylhydrazones derived from
(23) (1.056 g, 2.493 mmol) in tert-butanol (12.5 mL) was added potassium tert-butoxide
(0.582 g, 5.190 mmol). The reaction mixture was heated in a sealed pressure tube at 120 °C
for 18 h (CAUTION: evolved nitrogen was vented periodically during the first 4–6 h. Ample
head space in the tube was also provided). The reaction mixture was cooled, diluted with
water and isopropyl acetate and the layers separated. The aq layer was extracted with
isopropyl acetate (x3). The combined organic layers were washed with brine, dried over
anhyd MgSO4, filtered and concentrated under vacuum. The crude material was
chromatographed on silica gel (0 to 10% EtOAc in hexanes) to give (26) (0.597 g, 63%) as a
white solid. mp = 84.0 – 86.5 °C; 1H NMR (DMSO-d6, 500 MHZ, 90 °C) δ 6.29 (bs, 1H),
4.85 (d, J = 2.5 Hz, 1H), 3.40 (dd, J = 12.8, 7.4 Hz, 2H), 3.29 (m, 2H), 2.38 (d, J = 15.2 Hz,
1H), 2.29 (d, J = 15.2 Hz, 1H), 1.81 - 1.80 (m, 1H), 1.74 - 1.70 (m, 2H), 1.48 - 1.47 (m, 1H),
1.43 (s, 9H); 13C NMR (DMSO-d6, 125 MHz, 90 °C) δ 153.6, 143.6, 97.3, 82.6, 77.9, 50.5,
42.4, 37.2, 34.3, 27.4, 21.2; IR 2935, 1693 cm−1; HRMS (ESI-TOF) m/z calcd for (M + H
−Boc)+ (C8H14NO)+ 140.1075, found 140.1067.
tert-Butyl 1-oxa-7-azaspiro[4.4]non-2-ene-7-carboxylate (27)—Following the
above procedure for preparation of (26), using (24) as starting material (1.611 g, 6.680
mmol) and 4-methylbenzenesulfonohydrazide (1.865 g, 10.02 mmol) as reagent, the mixture
of tosylhydrazones (2.240 g, 82%) was obtained as a white, amorphous solid that was used
without further characterization.
Following the above procedure a solution of the tosylhydrazones derived from (24) (0.726 g,
1.772 mmol) in tert-butanol (10 mL) were reacted with potassium tert-butoxide (0.414 g,
3.690 mmol) to afford the product (27) (0.206 g, 52%) as a colorless oil. 1H NMR (CDCl3,
500 MHZ) δ 6.19 (s, 1H), 4.83 (dd, J = 5.2, 2.5 Hz, 1H), 3.73 - 3.36 (m, 3H), 3.23 (dd, J =
11.7, 6.4 Hz, 1H), 2.65 - 2.60 (m, 1H), 2.54 (d, J = 15.6 Hz, 1H), 2.16 - 2.12 (m, 1H), 1.85 -
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1.79 (m, 1H), 1.41 (s, 9H); 13C NMR (CDCl3, 125 MHz) ~1:1 mixture of rotamers; δ 154.3,
144.1, 98.8, 98.7, 90.8, 90.1, 79.2, 79.1, 57.4, 56.9, 45.1, 44.6, 37.8, 37.2, 36.7, 36.5, 28.4;
IR (neat) 2976, 1692 cm−1; HRMS (ESI-TOF) m/z calcd for (M + H)+ (C12H20NO3)+
226.1443, found 226.1459.
tert-Butyl 5-oxa-2-azaspiro[3.4]oct-6-ene-2-carboxylate (28)—Following the above
procedure for preparation of (26) with (25) as starting material (0.562 g, 2.473 mmol) and 4-
methylbenzenesulfonohydrazide (0.691 g, 3.710 mmol) as reagent, the derived
tosylhydrazones (0.678 g, 69%) were obtained as a white, amorphous solid.
Following the above procedure, a solution of the tosylhydrazones derived from (25) (0.602
g, 1.523 mmol) in tert-butanol (10 mL) were reacted with potassium tert-butoxide (0.355 g,
3.170 mmol) to afford the product (28) (0.140 g, 44%) as a white solid. mp = 58.1 – 60.4
°C; 1H NMR (CDCl3, 400 MHz) δ 6.24 (dd, J = 5.0, 2.4 Hz, 1H), 4.88 (dd, J = 2.4, 2.4 Hz,
1H), 4.14 (d, J = 10.0 Hz, 2H), 3.91 (d, J = 9.7 Hz, 2H), 2.83 (dd, J = 2.4, 2.4 Hz, 2H), 1.43
(s, 9H); 13C NMR (CDCl3, 100 MHz) δ 156.2, 144.5, 99.1, 80.0, 79.6, 63.7, 39.8, 28.3; IR
(neat) 2977, 1700 cm−1; HRMS (ESI-TOF) m/z calcd for (M + H)+ (C11H18NO3)+
212.1287, found 212.1292.
tert-Butyl 2-deutero-1-oxa-8-azaspiro[4.5]dec-2-ene-8-carboxylate (35)—A −78
°C solution of (26) (0.102 g, 0.428 mmol) in dry THF (3 mL) was treated with t-
butyllithium (0.660 mL of a 1.42 M solution in pentane, 0.941 mmol). The reaction mixture
was stirred for 20 min then warmed to −45 °C and stirred for an additional 2 h. The reaction
mixture was cooled back to −78 °C and anhyd methanol-d4 (1 mL) was added. The mixture
was stirred for 10 min then warmed to rt. The reaction mixture was diluted with toluene and
concentrated under vacuum. Toluene was again added giving a white suspension that was
filtered and concentrated under vacuum to give compound (35) (0.092 mg, 90%) as a white
solid. 1H NMR indicated complete conversion to the deuterated species as evidenced by the
absence of the enol ether α proton signal at δ 6.24. 1H NMR (CDCl3, 400 MHZ) δ 4.83 (d, J
= 2.3 Hz, 1H), 3.43 - 3.29 (m, 4H), 2.41 (m, 1H), 2.31 (dd, J = 15.2, 2.3 Hz, 1H), 1.92 - 1.65
(m, 3H), 1.55 - 1.40 (m, 10H); HRMS (ESI-TOF) m/z calcd for (M + H)+ (C13H21DNO3)+
241.1662, found 241.1680.
tert-Butyl 2-formyl-1-oxa-8-azaspiro[4.5]dec-2-ene-8-carboxylate (29)—To a −78
°C solution of (26) (0.094 g, 0.391 mmol) in THF (2.60 mL) was added t-butyllithium
(0.560 mL of a 1.55 M solution in pentane, 0.860 mmol). The reaction mixture was stirred
for 20 min then warmed to −45 °C and stirred for an additional 2 h. The reaction mixture
was then cooled back to −78 °C and N-formylpiperdine (1 mL) was added dropwise over 3–
4 min. The reaction mixture was stirred for 20 min then warmed to −45 °C and stirred for 18
h. The mixture was slowly warmed to 0 °C in 15 °C increments over 2 h and then stirred at 0
°C for an additional 1 h. The reaction was then quenched with satd aq NaHCO3. The
mixture was diluted with water and MTBE and the layers separated. The aq layer was
extracted with MTBE (x3) and the combined organic layers were washed with water (x2)
and brine (x1). The organic layer was dried over anhyd MgSO4, filtered and concentrated
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under vacuum. The crude material was chromatographed on silica gel (0 to 20% EtOAc in
hexanes) to give the product (29) (0.053 g, 51%) as a viscous brown oil and recovered
starting material (0.005 g, 5%) as a white solid. Reaction of (26) (0.102 mg), t-butyllithium
(0.620 mL of a 1.51 M solution in pentane, 0.934 mmol) and DMF (1 mL) in the same
fashion also afforded the product (29) (0.041 mg, 36%) with no recovered starting
material. 1H NMR (CDCl3, 500 MHZ, −45 °C), ~1:1 mixture of rotamers; δ 9.39 (s, 0.56
H), 9.36 (s, 0.44H), 6.09 (s, 0.56H), 6.06 (s, 0.44H), 3.95 - 3.56 (m, 2H), 3.10 - 2.79 (m,
2H), 2.79 - 2.51 (m, 2H), 1.85 - 1.74 (m, 3H), 1.45 - 1.38 (m, 1H), 1.37 (br s, 9H); 13C NMR
(CDCl3, 125 MHz, −45 °C) ~1:1 mixture of rotamers; δ 182.4, 154.9, 154.6, 154.5, 154.4,
121.7, 121.2, 85.6, 79.9, 50.8, 49.7, 43.2, 42.1, 38.8, 38.6, 35.1, 34.9, 28.0, 22.2, 21.9; IR
(neat) 2976, 1686 cm−1; HRMS (ESI-TOF) m/z calcd for (M + H)+ (C14H22NO4)+
268.1549, found 268.1571.
di-tert-Butyl 5-oxa-2-azaspiro[3.4]oct-6-ene-2,6-dicarboxylate (34)—Following
the above procedure for preparation of (29), compound (31) (0.103 g, 0.488 mmol) was
reacted with t-butyllithium (0.886 mL of a 1.21 M solution in pentane, 1.073 mmol) and N-
formylpiperdine (1 mL, excess). The by-product (34) (0.003 mg, 2%) was isolated as a
white solid. 1H NMR (CDCl3, 400 MHz) δ 5.84 (t, J = 3.0 Hz, 1H), 4.25 (dd, J = 9.6, 0.9
Hz, 2H), 3.97 (d, J = 9.6 Hz, 2H), 2.97 (d, J = 3.0 Hz, 2H), 1.46 (s, 9H), 1.25 (s, 9H); 13C
NMR (CDCl3, 100 MHz) δ 198.0, 156.2, 153.9, 109.4, 81.4, 80.0, 43.5, 40.2, 29.7, 28.3,
25.9; IR (neat) 2928, 1707, 1608 cm−1. No molecular ion was observed.
tert-Butyl 2-(hydroxymethyl)-1-oxa-8-azaspiro[4.5]dec-2-ene-8-carboxylate (32)
—To a solution of (29) (0.030 g, 0.111 mmol) in absolute ethanol (1.11 mL) was added
sodium borohydride (0.005 g, 0.133 mmol). The reaction mixture was stirred for 30 min
then diluted with toluene, filtered through a pad of celite and concentrated under vacuum.
The residue was redissolved in a 1:1 solution of DCM:EtOAc and filtered through a 1 g
silica gel SPE that had been pretreated with a solution of 2% triethylamine in hexanes.
Further elution was done with EtOAc, affording the pure product (32) (0.019 g, 65%) as a
viscous brown oil. 1H NMR (CDCl3, 400 MHZ) δ 4.82 (br s, 1H), 4.08 (br s, 2H), 3.93 -
3.06 (br m, 4H), 2.79 - 2.76 (m, 1H), 2.39 - 2.35 (m, 2H), 2.05 - 1.73 (br m, 2H), 1.72 - 1.70
(m, 1H), 1.58 - 1.50 (m, 1H), 1.46 (s, 9H); 13C NMR (CDCl3, 125 MHz, −45 °C) ~2:1
mixture of rotamers; Rotamer 1: δ 156.6, 154.5, 97.8, 84.8, 80.0, 57.6, 50.2, 44.6, 38.1,
34.0, 28.1, 22.1; Rotamer 2: δ 154.8, 154.3, 95.7; 84.0, 79.8, 58.1, 51.3, 42.4, 38.2, 35.1,
28.2, 22.0; IR: 3426, 2933, 1676 cm−1; HRMS (ESI-TOF) m/z calcd for (M + H−Boc)+
(C9H16NO2)+ 170.1181, found 170.1203.
8-(tert-Butoxycarbonyl)-1-oxa-8-azaspiro[4.5]dec-2-ene-2-carboxylic acid (33)
—In a manner similar to Snider,16 to a solution of (29) (0.027 mg, 0.099 mmol) and 2-
methyl-2-butene (0.238 mL or a 2M solution in THF, 0.476 mmol) in tert-butanol (0.90 mL)
at 0 °C was added a solution of sodium chlorite (0.012 mg of an 80 wt% solid, 0.109 mmol)
and monobasic sodium phosphite hydrate (0.015 g, 0.109 mmol) in water (0.10 mL). The
reaction mixture was warmed to rt and stirred for 90 min. The mixture was diluted with
water and acidified to pH ~3.00 with 0.1 M aq HCl as determined by pH meter. The mixture
was extracted into EtOAc (x3) and the combined organic layers were dried over anhyd
MgSO4, filtered, and concentrated under vacuum. The crude material was chromatographed
on silica gel (1% AcOH, 30% EtOAc in hexanes) to afford (33) (0.013 g, 45%) as an
amorphous white solid. 1H NMR (CDCl3, 500 MHZ, 50 °C) δ 5.95 (t, J = 2.8 Hz, 1H), 3.51
- 3.43 (m, 2H), 3.41 (d, J = 13.2 Hz, 1H), 3.32 - 3.28 (m, 1H), 2.65 (dd, J = 17.6, 2.8 Hz,
1H), 2.53 (dd, J = 17.6, 2.8 Hz, 1H), 2.06 - 1.78 (m, 4H), 1.60 - 1.42 (m, 10H); 13C NMR
(CDCl3, 125 MHz, 50 °C) δ 162.4, 155.4, 146.7, 111.2, 85.9, 80.2, 51.4, 43.7, 39.3, 35.5,
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28.5, 22.4; IR (neat) 3480, 2950, 1693, 1633 cm−1; HRMS (ESI-TOF) m/z calcd for (M + H
−Boc)+ (C9H14NO3)+ 184.0974, found 184.0961.
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Refer to Web version on PubMed Central for supplementary material.
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Representation of a family of spirocyclic scaffolds
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Distances between H’s on C9, C4 and C2 in Å as measured by MM2 models.
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Byproduct from lithiation/formylation reaction of 28.
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General synthesis scheme of racemic spiro-THF scaffolds from N-Boc protected cyclic 2-
aminoketones
Kumar et al. Page 20














Racemic spiro-THF scaffolds derived from N-Boc-3-piperidone 1
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Racemic spiro-THF scaffolds from N-Boc-3-pyrrolidinone 2
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Racemic spiro-THF scaffolds derived from N-Boc-3-azetidinone 3
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Synthesis of spiro-DHF scaffolds from N-Boc protected spirocyclic 3-furanones
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